Syverson Strege & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
6,006
+1,414
| +31% | +$262K | 0.26% | 44 |
|
|
2025
Q1 | $962K | Buy |
4,592
+38
| +0.8% | +$7.96K | 0.31% | 31 |
|
|
2024
Q4 | $809K | Buy |
4,554
+1,304
| +40% | +$232K | 0.27% | 32 |
|
|
2024
Q3 | $642K | Sell |
3,250
-806
| -20% | -$159K | 0.22% | 36 |
|
|
2024
Q2 | $696K | Buy |
+4,056
| New | +$696K | 0.24% | 35 |
|
|
2022
Q3 | – | Sell |
-75
| Closed | -$11K | – | 281 |
|
|
2022
Q2 | $11K | Buy |
+75
| New | +$11K | ﹤0.01% | 215 |
|
|
2022
Q1 | – | Sell |
-20
| Closed | -$3K | – | 297 |
|
|
2021
Q4 | $3K | Sell |
20
-9
| -31% | -$1.35K | ﹤0.01% | 251 |
|
|
2021
Q3 | $3K | Buy |
+29
| New | +$3K | ﹤0.01% | 360 |
|